Home › Germany's Merck cautious after deal spree
 

Keywords :   


Germany's Merck cautious after deal spree

2015-03-03 10:15:59| Chemicals - Topix.net

Germany's Merck KGaA forecasts little or no improvement in earnings this year after a slight drop in fourth-quarter net profit, with stiff competition for its blockbuster multiple-sclerosis treatment and higher research spending likely to offset the impact of recent acquisitions. Multiple-sclerosis drug Rebif faces strong competition in North America and Europe while Merck continues to spend on developing new cancer treatments.

Tags: deal cautious merck spree

Category:Chemicals

Latest from this category

All news
04.10RPM General Counsel Edward W. Moore to Retire
04.10AkzoNobel to Review Portfolio with Early Focus on Deco South Asia
03.10AkzoNobel Goes Extra Mile to Help Residents of Worlds Highest Motorable Village
03.10PPG Wins 2024 Supplier Excellence Award from Caterpillar Inc.
02.10RPM Reports Record Fiscal 1Q 2025 Results
02.10Evonik Breaks Ground on Major Silica Expansion at Charleston
01.10BCF CEO Tom Bowtell is Honored for Outstanding Leadership
01.10Green Seal Unveils New Brand Identity
Chemicals »
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
More »